Biosynex Balance Sheet Health
Financial Health criteria checks 2/6
Biosynex has a total shareholder equity of €124.3M and total debt of €66.0M, which brings its debt-to-equity ratio to 53.1%. Its total assets and total liabilities are €241.7M and €117.4M respectively.
Key information
53.1%
Debt to equity ratio
€65.96m
Debt
Interest coverage ratio | n/a |
Cash | €26.16m |
Equity | €124.32m |
Total liabilities | €117.41m |
Total assets | €241.73m |
Recent financial health updates
Biosynex (EPA:ALBIO) Could Easily Take On More Debt
Jun 23We Think Biosynex (EPA:ALBIO) Can Stay On Top Of Its Debt
Dec 19Recent updates
Biosynex SA (EPA:ALBIO) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Mar 12Biosynex SA's (EPA:ALBIO) Shares Not Telling The Full Story
Jan 20Returns On Capital Are Showing Encouraging Signs At Biosynex (EPA:ALBIO)
May 05Investors Shouldn't Overlook Biosynex's (EPA:ALBIO) Impressive Returns On Capital
Dec 01Biosynex (EPA:ALBIO) Could Easily Take On More Debt
Jun 23If You Like EPS Growth Then Check Out Biosynex (EPA:ALBIO) Before It's Too Late
Jul 11Here's Why I Think Biosynex (EPA:ALBIO) Is An Interesting Stock
Apr 06We Think Biosynex (EPA:ALBIO) Can Stay On Top Of Its Debt
Dec 19Financial Position Analysis
Short Term Liabilities: ALBIO's short term assets (€91.4M) exceed its short term liabilities (€24.8M).
Long Term Liabilities: ALBIO's short term assets (€91.4M) do not cover its long term liabilities (€92.7M).
Debt to Equity History and Analysis
Debt Level: ALBIO's net debt to equity ratio (32%) is considered satisfactory.
Reducing Debt: ALBIO's debt to equity ratio has increased from 17.7% to 53.1% over the past 5 years.
Debt Coverage: ALBIO's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if ALBIO's interest payments on its debt are well covered by EBIT.